Armistice Capital
DICE icon

Armistice Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Armistice Capital’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,376,000
Closed -$39.4M – 289
2023
Q1 		$39.4M Buy
+1,376,000
New +$40.8M 0.57% 41

Other funds holding DICE

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Alpine Associates Management
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Pentwater Capital Management
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Armistice Capital's DICE Position: Q2 2023 in Review

Armistice Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 1,376,000 shares — an estimated $39.4M sold.

Armistice Capital first reported a position in DICE in Q1 2023 and held it in 1 quarter. The position peaked at $39.4M in Q1 2023. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

  • Armistice Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Armistice Capital sold 1,376,000 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $39.4M.
  • Armistice Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Armistice Capital's DICE Therapeutics, Inc. Common Stock position peaked at $39.4M in Q1 2023.
  • 160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.